Clinical trials show average weight loss of 7-10% of body weight over one year at the highest dose
Initially developed for type 2 diabetes, GLP-1RAs have demonstrated robust weight loss in randomized controlled trials and real-world settings, leading to their repositioning as cornerstone obesity treatments ( Human metabolic studies consistently show that reductions in energy intake account for most of the weight loss observed during GLP-1RA therapy, whereas increases in resting energy expenditure are modest or absent ( Beyond total weight loss, the quality of weight loss has become an increasingly important clinical concern
Formulated with premium multi-active complex: Sodium Hyaluronate instantly replenishes and locks long-lasting moisture for emergency hydration
Variants in GLP1R, GIPR, FTO, and MC4R genes correlate with differential GLP-1 responsiveness, though genetics alone does not determine outcome
At 1500mg IV, plasma glutathione levels rise significantly within minutes, delivering immediate systemic antioxidant support
Others get destroyed by stomach acid before they ever reach your bloodstream